中信加速器2024年-outline

中信加速器2024年-outline

ESI BIO's mission is to provide our customers with end-to-end solutions from stem cell discovery through clinical manufacturing using products that are translatable to the clinic. To date, we have made great strides in creating reagents not only for research purposes but in providing the assurance that these products will be compatible for use in clinical trials.

中信加速器2024年-outline

• VascuNet™ Pericyte Co-Culture Assay

• HyStem® UV QuickSet Hydrogels

• BioLite™ Live Stain Antibodies

• ESI Human Embryonic Stem Cells

中信加速器2024年-outline

• ESI BIO Launches New Research Technology Platform, VascuNet™ Pericyte Co-Culture Assay »
• BioTime’s Clinical Grade Stem Cells From Subsidiary ES Cell International to Be Used in Planned CIRM-Funded Preclinical Studies of Huntington’s Disease »
• ES Cell International Licenses Beckman Research Institute of City of Hope to Manufacture Clinical Grade Stem Cells »